These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 22257645)

  • 21. Ovarian function is effectively inhibited by a low-dose triphasic oral contraceptive containing ethinylestradiol and levonorgestrel.
    Gaspard UJ; Dubois M; Gillain D; Franchimont P; Duvivier J
    Contraception; 1984 Apr; 29(4):305-18. PubMed ID: 6430638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-dose estrogen combined oral contraceptives may negatively influence physiological bone mineral density acquisition during adolescence.
    Cibula D; Skrenkova J; Hill M; Stepan JJ
    Eur J Endocrinol; 2012 Jun; 166(6):1003-11. PubMed ID: 22436400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low dose dehydroepiandrosterone affects behavior in hypopituitary androgen-deficient women: a placebo-controlled trial.
    Johannsson G; Burman P; Wirén L; Engström BE; Nilsson AG; Ottosson M; Jonsson B; Bengtsson BA; Karlsson FA
    J Clin Endocrinol Metab; 2002 May; 87(5):2046-52. PubMed ID: 11994339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of dehydroepiandrosterone supplementation on bone mineral density, bone markers, and body composition in older adults: the DAWN trial.
    von Mühlen D; Laughlin GA; Kritz-Silverstein D; Bergstrom J; Bettencourt R
    Osteoporos Int; 2008 May; 19(5):699-707. PubMed ID: 18084691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An investigation into the effect of tenidap sodium on the pharmacokinetics of a combined oral contraceptive.
    Coates PE; Mesure R
    Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):47S-50S. PubMed ID: 7547095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sex-specific effects of dehydroepiandrosterone (DHEA) on bone mineral density and body composition: A pooled analysis of four clinical trials.
    Jankowski CM; Wolfe P; Schmiege SJ; Nair KS; Khosla S; Jensen M; von Muhlen D; Laughlin GA; Kritz-Silverstein D; Bergstrom J; Bettencourt R; Weiss EP; Villareal DT; Kohrt WM
    Clin Endocrinol (Oxf); 2019 Feb; 90(2):293-300. PubMed ID: 30421439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris.
    Lucky AW; Henderson TA; Olson WH; Robisch DM; Lebwohl M; Swinyer LJ
    J Am Acad Dermatol; 1997 Nov; 37(5 Pt 1):746-54. PubMed ID: 9366821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of DHEA replacement on bone mineral density and body composition in elderly women and men.
    Villareal DT; Holloszy JO; Kohrt WM
    Clin Endocrinol (Oxf); 2000 Nov; 53(5):561-8. PubMed ID: 11106916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The bioequivalence of the contraceptive steroids ethinylestradiol and drospirenone is not affected by co-administration of dehydroepiandrosterone.
    Zimmerman Y; Wouters W; Coelingh Bennink HJ
    Eur J Contracept Reprod Health Care; 2013 Jun; 18(3):206-14. PubMed ID: 23550808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Maintaining physiologic testosterone levels during combined oral contraceptives by adding dehydroepiandrosterone: II. Effects on sexual function. A phase II randomized, double-blind, placebo-controlled study.
    van Lunsen RHW; Zimmerman Y; Coelingh Bennink HJT; Termeer HMM; Appels N; Fauser BCJM; Laan E
    Contraception; 2018 Jul; 98(1):56-62. PubMed ID: 29490289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hormonal treatment for bleeding irregularities in Norplant implant users.
    Alvarez-Sanchez F; Brache V; Thevenin F; Cochon L; Faundes A
    Am J Obstet Gynecol; 1996 Mar; 174(3):919-22. PubMed ID: 8633669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of a combination of ethinylestradiol and desogestrel in adolescents with oligomenorrhea and ovarian hyperandrogenism.
    Nappi C; Farace MJ; Leone F; Minutolo M; Tommaselli AP; Montemagno U
    Eur J Obstet Gynecol Reprod Biol; 1987 Jul; 25(3):209-19. PubMed ID: 2956138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial.
    Hunt PJ; Gurnell EM; Huppert FA; Richards C; Prevost AT; Wass JA; Herbert J; Chatterjee VK
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4650-6. PubMed ID: 11134123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Dehydroepiandrosterone And WellNess (DAWN) study: research design and methods.
    von Mühlen D; Laughlin GA; Kritz-Silverstein D; Barrett-Connor E
    Contemp Clin Trials; 2007 Feb; 28(2):153-68. PubMed ID: 16784898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of dehydroepiandrosterone (DHEA) supplementation on hormonal, metabolic and behavioral status in patients with hypoadrenalism.
    Libè R; Barbetta L; Dall'Asta C; Salvaggio F; Gala C; Beck-Peccoz P; Ambrosi B
    J Endocrinol Invest; 2004 Sep; 27(8):736-41. PubMed ID: 15636426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physiologic Transdermal Estradiol Replacement Mimics Effects of Endogenous Estrogen on Bone Outcomes in Hypoestrogenic Women with Anorexia Nervosa.
    Singhal V; Nimmala S; Slattery M; Eddy KT; Miller KK; Klibanski A; Misra M
    Nutrients; 2022 Jun; 14(13):. PubMed ID: 35807738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of dehydroepiandrosterone replacement therapy on bone mineral density in older adults: a randomized, controlled trial.
    Jankowski CM; Gozansky WS; Schwartz RS; Dahl DJ; Kittelson JM; Scott SM; Van Pelt RE; Kohrt WM
    J Clin Endocrinol Metab; 2006 Aug; 91(8):2986-93. PubMed ID: 16735495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of estrogen administration on bone mineral density in adolescents with anorexia nervosa.
    Muñoz MT; Morandé G; García-Centenera JA; Hervás F; Pozo J; Argente J
    Eur J Endocrinol; 2002 Jan; 146(1):45-50. PubMed ID: 11751066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of dehydroepiandrosterone on lumbar spine bone mineral density in patients with quiescent systemic lupus erythematosus.
    Hartkamp A; Geenen R; Godaert GL; Bijl M; Bijlsma JW; Derksen RH
    Arthritis Rheum; 2004 Nov; 50(11):3591-5. PubMed ID: 15529389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of an oral contraceptive (norgestimate/ethinyl estradiol) on bone mineral density in adolescent females with anorexia nervosa: a double-blind, placebo-controlled study.
    Strokosch GR; Friedman AJ; Wu SC; Kamin M
    J Adolesc Health; 2006 Dec; 39(6):819-27. PubMed ID: 17116511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.